<DOC>
	<DOCNO>NCT00147355</DOCNO>
	<brief_summary>This substudy open-label , randomise study compare uptake recombinant interleukin-2 ( rIL-2 ) HIV-1 infected individual receive different combination antiemetic analgesic agent rIL-2 dose ESPRIT . The design factorial one 4 arm . All patient receive regular ibuprofen paracetamol day 1-6 rIL-2 dosing cycle ; addition , patient randomise receive one two antiemetic combination , i.e . ondansetron metoclopramide without low dose codeine phosphate additional analgesic agent .</brief_summary>
	<brief_title>Toxicity Substudy Evaluation Subcutaneous Proleukin Randomised International Trial ( ESPRIT ) : TOXIL-2 Substudy</brief_title>
	<detailed_description>The research randomise open-label substudy ESPRIT . The substudy explore whether amount rIL-2 take dosing cycle rIL-2 increase control predictable side-effects rIL-2 well . This four arm study factorial design ; patient randomise one four arm . Each arm consist different combination adjunctive agent . Each patient receive paracetamol ibuprofen prophylactically throughout cycle , adjunctive agent prescribe vary accord arm patient randomise , antiemetic use either ondansetron metoclopramide without low dose codeine phosphate additional analgesic agent . The primary end-point percentage plan rIL-2 actually take cycle . Secondary end-points include safety , side-effects rIL-2 adjunctive agent , CD4+ T-cell change quality life measure .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Codeine</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<mesh_term>Ondansetron</mesh_term>
	<mesh_term>Metoclopramide</mesh_term>
	<criteria>Patients participate ESPRIT randomise rIL2 arm , : 1 . Are CD4+ Tcell target protocol 2 . Have receive rIL2 &gt; 2 month 3 . Have report GI upset constitutional sideeffects one reason either dose modifying prior cycle unwillingness receive rIL2 4 . Are consider Investigator medically safe receive dose rIL2 5 . Are willing receive dosing rIL2 dose specify Investigator 6 . Are willing sign inform consent participate substudy 1 . All exclusion receipt rIL2 ESPRIT 2 . Known allergy nonsteroidal antiinflammatory drug ( NSAIDs ) , opiates , 5HT3 ( serotonin3 ) inhibitor , antidopaminergic antiemetic , component propose adjunct regimen . 3 . Use NSAIDs ( cyclooxygenase2 [ COX2 ] inhibitor , corticosteroid ) opiate analgesic within two week rIL2 dose . Use low dose aspirin cardioprotective agent allow .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>rIL-2-toxicity</keyword>
	<keyword>interleukin-2 therapy</keyword>
	<keyword>HIV</keyword>
	<keyword>Toxicity substudy ESPRIT</keyword>
</DOC>